Enhancing the Clinical Utility of DriveSafe DriveAware for People with Huntington’s Disease-Reference-Cited by-同舟云学术

Enhancing the Clinical Utility of DriveSafe DriveAware for People with Huntington’s Disease

Published:2020-12-08 Issue:4 Volume:9 Page:353-357
ISSN:1879-6397
Container-title:Journal of Huntington's Disease
language:
Short-container-title:JHD

Author:

Sondhu Monique K.¹,Fisher Fiona²,Stout Julie C.¹

Affiliation:

1. School of Psychological Sciences and the Turner Institute for Brain and Mental Health, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia

2. Calvary Health Care Bethlehem, State-wide Progressive Neurological Disease Service, Caulfield South, Victoria, Australia

Abstract

DriveSafe DriveAware (DSDA) is a cognitive screening tool assessing driving safety. Previously, we found DSDA categorised some HD participants as ‘likely to pass’ on-road assessments, despite displaying cognitive impairments in domains known to impact driving. As processing speed is affected early in HD, we examined whether DSDA completion time could provide supplementary cognitive information to support clinical decision-making. The HD group completed subtests significantly slower than controls, and completion times correlated with cognitive functions essential for driving. Considering DSDA completion time may tailor the assessment for people with HD so that it is more reflective of HD-related cognitive functioning.

Publisher

IOS Press

Subject

Cellular and Molecular Neuroscience,Neurology (clinical)

Reference21 articles.

1. Huntington disease: Natural history, biomarkers and prospects for therapeutics;Ross;Nat Rev Neurol,2014

2. Huntington’s disease genetics;Myers;NeuroRX,2004

3. Huntington’s disease;Walker;Lancet,2007

4. The cognitive burden in Huntington’s disease: Pathology, phenotype, and mechanisms of compensation;Papoutsi;Mov Disord,2014

5. Neurocognitive signs in prodromal Huntington disease;Stout;Neuropsychology,2011